The Benefits of Physical Exercise on Epilepsy Treatment: Possible Mechanisms via Neurotransmitters Modulation
This narrative review aims to critically explored current preclinical and clinical evidence on the therapeutic benefits of physical exercise in epilepsy management, with particular emphasis on the underlying mechanisms mediated by modulation of key neurotransmitter systems, including GABAergic, glutamatergic, monoaminergic, and neurotrophic pathways. It seeks to reframe exercise from a historically perceived risk factor to a promising non-pharmacological adjunct capable of reducing seizure susceptibility and improving comorbid outcomes. A comprehensive narrative synthesis of the literature was conducted by searching major databases (PubMed/MEDLINE, Scopus, Web of Science) for peer-reviewed English-language studies examining physical exercise or activity in experimental epilepsy models and people with epilepsy. Inclusion prioritized investigations of neurotransmitter alterations (GABA, glutamate, dopamine, serotonin, noradrenaline), BDNF signaling, neuroinflammation, oxidative stress, and related clinical endpoints such as seizure frequency, cognition, and quality of life. Accumulating evidence demonstrates that regular moderate-to-vigorous aerobic and resistance exercise reduces seizure frequency and severity in animal models and selected clinical cohorts, while concurrently ameliorating depression, anxiety, cognitive deficits, and overall quality of life. Mechanistically, exercise elevates brain GABA levels and GABAergic neurosteroids, restores excitatory–inhibitory balance by modulating glutamate, enhances monoaminergic transmission (dopamine, serotonin, noradrenaline), and robustly upregulates hippocampal BDNF and downstream plasticity pathways (ERK/mTOR). Physical exercise emerges as a safe, accessible, and multifaceted complementary strategy in epilepsy treatment, exerting anticonvulsant and neuroprotective actions principally through neurotransmitter modulation and neurotrophic support. Integration of structured exercise into multidisciplinary care is warranted, although larger randomized trials are needed to optimize intensity, modality, and patient stratification, particularly in drug-resistant epilepsy. Exercise may enhance GABAergic function and attenuate pathological glutamatergic activity, particularly after repeated training in experimental epilepsy models. Exercise may modulate serotonergic, dopaminergic, and noradrenergic signaling, but the direction and functional significance of these changes depend on exercise characteristics and experimental context. Adenosine and lactate provide potential metabolic links between exercise-related energy demand and neuronal excitability, although their antiseizure relevance in humans remains uncertain. BDNF–TrkB signaling may contribute to exercise-related synaptic plasticity, neuronal resilience, and excitatory–inhibitory network organization, but is not established as a universal mediator of neurotransmitter adaptation. Exercise-related adaptations in oxidative stress, neuroinflammation, mitochondrial function, and neuroplasticity may contribute to greater network resilience and reduced seizure susceptibility. Mechanistic evidence remains predominantly preclinical, and direct links between exercise-induced molecular changes and seizure outcomes in people with epilepsy remain limited. The schematic summarizes a proposed framework in which epilepsy is characterized by network hyperexcitability driven by excitation–inhibition imbalance, altered glutamatergic and GABAergic signaling, dysregulation of other neurotransmitter systems, and interacting processes including oxidative stress, mitochondrial dysfunction, neuroinflammation, and impaired neuroplasticity. Regular physical exercise is depicted as a protocol-dependent intervention that induces systemic and neurobehavioral adaptations, including improved circulation, metabolic support, sleep, mood, and fitness, with potential clinical benefit in people with epilepsy. These adaptations converge on reduced seizure susceptibility through modulation of GABAergic/glutamatergic balance, serotonergic, dopaminergic, noradrenergic, cholinergic, and glycinergic pathways, as well as through effects on adenosine and lactate, HPA-axis and stress-related signaling, oxidative stress, neuroinflammation, neuroplasticity, and possibly epigenetic regulation.
Authors
- Atousa Janzadeh (ORCID: https://orcid.org/0000-0003-2716-4526)
- Fatemeh Bagheri Tadi (ORCID: https://orcid.org/0000-0002-3416-0198)
- Rahil Mohajerian
- Parnian Amani
- Soroush Taherkhani
Publication Details
- Journal
- Figshare
- Published
- 2026-11-20
- DOI
- https://doi.org/10.6084/m9.figshare.35076926
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00